Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 4 | 2018 | 283 | 0.370 |
Why?
|
| Nociceptors | 3 | 2017 | 19 | 0.270 |
Why?
|
| Chronic Pain | 2 | 2018 | 127 | 0.230 |
Why?
|
| Neurons | 2 | 2017 | 273 | 0.220 |
Why?
|
| Osteoarthritis, Knee | 2 | 2017 | 299 | 0.200 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2020 | 9 | 0.170 |
Why?
|
| Calcium | 3 | 2018 | 369 | 0.160 |
Why?
|
| Hyperalgesia | 2 | 2017 | 46 | 0.160 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Aggrecans | 1 | 2018 | 51 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 526 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 100 | 0.130 |
Why?
|
| Arthritis, Experimental | 2 | 2018 | 52 | 0.130 |
Why?
|
| Mice | 5 | 2020 | 1263 | 0.120 |
Why?
|
| Animals | 6 | 2020 | 3311 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 25 | 0.120 |
Why?
|
| Knee Joint | 1 | 2017 | 572 | 0.100 |
Why?
|
| Receptors, CCR2 | 1 | 2012 | 10 | 0.100 |
Why?
|
| Chemokine CCL2 | 3 | 2018 | 19 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2018 | 282 | 0.080 |
Why?
|
| Pain | 2 | 2020 | 332 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 373 | 0.050 |
Why?
|
| Ganglia, Spinal | 2 | 2015 | 57 | 0.050 |
Why?
|
| Male | 4 | 2020 | 12466 | 0.050 |
Why?
|
| Collagen Type V | 1 | 2020 | 3 | 0.040 |
Why?
|
| Skin | 1 | 2020 | 118 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 330 | 0.040 |
Why?
|
| ADAMTS4 Protein | 1 | 2018 | 15 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2018 | 6 | 0.040 |
Why?
|
| ADAMTS5 Protein | 1 | 2018 | 20 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 18 | 0.040 |
Why?
|
| Ganglion Cysts | 1 | 2018 | 6 | 0.030 |
Why?
|
| Nociception | 1 | 2018 | 10 | 0.030 |
Why?
|
| Central Nervous System Sensitization | 1 | 2017 | 3 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 53 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 55 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 174 | 0.030 |
Why?
|
| Analgesics | 1 | 2018 | 78 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 2017 | 94 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 202 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 5 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2018 | 267 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2015 | 469 | 0.030 |
Why?
|
| Female | 2 | 2020 | 12958 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 89 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 284 | 0.020 |
Why?
|
| Humans | 3 | 2018 | 22958 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 398 | 0.020 |
Why?
|